Scotiabank Increases DRI Healthcare Trust (TSE:DHT.UN) Price Target to C$22.00

DRI Healthcare Trust (TSE:DHT.UN) had its price objective lifted by Scotiabank from C$21.00 to C$22.00 in a report published on Tuesday morning, BayStreet.CA reports. Scotiabank currently has an outperform rating on the stock.

DHT.UN has been the subject of a number of other research reports. Truist Financial decreased their price objective on shares of DRI Healthcare Trust from C$17.00 to C$14.00 in a research note on Thursday, July 25th. Royal Bank of Canada lowered their price target on DRI Healthcare Trust from C$20.00 to C$16.00 in a research note on Tuesday, July 9th. CIBC reduced their price objective on shares of DRI Healthcare Trust from C$20.00 to C$18.50 in a research note on Tuesday, July 9th. National Bankshares lowered their price target on shares of DRI Healthcare Trust from C$23.50 to C$17.50 and set an outperform rating on the stock in a report on Tuesday, July 9th. Finally, Stifel Nicolaus lowered shares of DRI Healthcare Trust from a buy rating to a hold rating and reduced their price target for the stock from C$22.00 to C$15.00 in a research report on Tuesday, July 9th. One research analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, DRI Healthcare Trust presently has an average rating of Moderate Buy and a consensus target price of C$18.25.

DRI Healthcare Trust Trading Up 36.8 %

DHT.UN opened at C$14.42 on Tuesday. The company’s 50-day moving average price is C$12.56 and its 200 day moving average price is C$14.08. DRI Healthcare Trust has a fifty-two week low of C$10.39 and a fifty-two week high of C$17.43.

DRI Healthcare Trust Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, October 18th will be given a dividend of $0.085 per share. The ex-dividend date is Friday, September 27th. This represents a $0.34 annualized dividend and a yield of 2.36%. DRI Healthcare Trust’s payout ratio is currently -920.00%.

About DRI Healthcare Trust

DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.